0001363763-17-000003.txt : 20170120 0001363763-17-000003.hdr.sgml : 20170120 20170120211036 ACCESSION NUMBER: 0001363763-17-000003 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170118 FILED AS OF DATE: 20170120 DATE AS OF CHANGE: 20170120 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: RespireRx Pharmaceuticals Inc. CENTRAL INDEX KEY: 0000849636 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 330303583 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 126 VALLEY ROAD STREET 2: SUITE C CITY: GLEN ROCK STATE: NJ ZIP: 07452 BUSINESS PHONE: (201) 444-4947 MAIL ADDRESS: STREET 1: 126 VALLEY ROAD STREET 2: SUITE C CITY: GLEN ROCK STATE: NJ ZIP: 07452 FORMER COMPANY: FORMER CONFORMED NAME: CORTEX PHARMACEUTICALS INC/DE/ DATE OF NAME CHANGE: 19920703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: WEINGARTEN ROBERT N CENTRAL INDEX KEY: 0001135337 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-16467 FILM NUMBER: 17539716 MAIL ADDRESS: STREET 1: 5439 LOCKHURST DRIVE CITY: WOODLAND HILLS STATE: CA ZIP: 91367 4 1 primary_doc.xml PRIMARY DOCUMENT X0306 4 2017-01-18 0 0000849636 RespireRx Pharmaceuticals Inc. RSPI 0001135337 WEINGARTEN ROBERT N C/O RESPIRERX PHARMACEUTICALS INC. 126 VALLEY ROAD, SUITE C GLEN ROCK NJ 07452 1 1 0 0 EVP & Chief Financial Officer Common Stock Options (to purchase shares of Common Stock) 3.9 2017-01-18 4 A 0 50000 0 A 2022-01-18 Common Stock 50000 50000 D Common Stock Options (to purchase shares of Common Stock) 7.3775 2021-03-31 Common Stock 73847 73847 D Common Stock Options (to purchase shares of Common Stock) 6.396 2022-08-18 Common Stock 30770 30770 D Common Stock Options (to purchase shares of Common Stock) 8.125 2022-06-30 Common Stock 46154 46154 D Common Stock Options (to purchase shares of Common Stock) 16.25 2019-07-17 Common Stock 15385 15385 D These Common Stock Options vest in three installments: 25 percent on January 18, 2017 (the grant date), 25 percent on March 31, 2017, and 50 percent on June 30, 2017. The exercise price and number of shares of these securities have been adjusted to reflect the Company's 325-to-1 reverse stock split effective September 1, 2016. These Common Stock Options vested in four equal installments: 25 percent on March 31, 2016 (the grant date), 25 percent on June 30, 2016, 25 percent on September 30, 2016, and 25 percent on December 31, 2016, and are all currently vested and exercisable. These Common Stock Options vested in four equal installments: 25 percent on December 31, 2015, 25 percent on March 31, 2016, 25 percent on June 30, 2016, and 25 percent on September 30, 2016, and are all currently vested and exercisable. These Common Stock Options vest in three installments: 50 percent on June 30, 2015, 25 percent on September 30, 2015, and 25 percent on December 31, 2015, and are all currently vested and exercisable. These Common Stock Options vested in three equal installments on July 17, 2014, September 30, 2014 and December 31, 2014, and are all currently vested and exercisable. /s/ Robert N. Weingarten 2017-01-20